When administered with r-tPA, specific MMP-9 inhibitors markedly reduced brain hemorrhage, swelling, infarction, disability and death, suggesting that blocking the deleterious effects of MMP-9 may improve outcomes after ischemic stroke [26]. The gene discussed is MMP9; the disease is ischemic stroke.